ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.38
+0.13 (1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
8.35
-0.03 (-0.36%)
After-hours: Apr 28, 2026, 4:10 PM EDT
ImmuCell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 27.64 | 26.49 | 17.47 | 18.57 | 19.24 | Upgrade
|
| Revenue Growth (YoY) | 4.35% | 51.63% | -5.90% | -3.51% | 25.42% | Upgrade
|
| Cost of Revenue | 16.2 | 18.55 | 13.08 | 10.33 | 10.59 | Upgrade
|
| Gross Profit | 11.45 | 7.94 | 4.4 | 8.24 | 8.66 | Upgrade
|
| Selling, General & Admin | 5.95 | 5.68 | 5.22 | 5.45 | 4.23 | Upgrade
|
| Research & Development | 3.04 | 3.9 | 4.39 | 4.49 | 4.17 | Upgrade
|
| Operating Expenses | 9 | 9.58 | 9.62 | 9.95 | 8.4 | Upgrade
|
| Operating Income | 2.45 | -1.64 | -5.22 | -1.71 | 0.26 | Upgrade
|
| Interest Expense | -0.49 | -0.57 | -0.48 | -0.35 | -0.31 | Upgrade
|
| Interest & Investment Income | 0.16 | 0.08 | 0.1 | 0.15 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | 0 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | 2.12 | -2.13 | -5.6 | -1.9 | -0.04 | Upgrade
|
| Merger & Restructuring Charges | -0.8 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.11 | -0.02 | -0.01 | 0.01 | -0.03 | Upgrade
|
| Asset Writedown | -2.67 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.53 | -0.59 | - | Upgrade
|
| Pretax Income | -1.03 | -2.15 | -5.77 | -2.49 | -0.07 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0 | 0.01 | 0.01 | Upgrade
|
| Net Income | -1.04 | -2.16 | -5.77 | -2.49 | -0.08 | Upgrade
|
| Net Income to Common | -1.04 | -2.16 | -5.77 | -2.49 | -0.08 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | 10.52% | 5.42% | 0.03% | 2.01% | 5.25% | Upgrade
|
| EPS (Basic) | -0.12 | -0.26 | -0.75 | -0.32 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.12 | -0.26 | -0.75 | -0.32 | -0.01 | Upgrade
|
| Free Cash Flow | 1.22 | -0.11 | -6.57 | -5.52 | -1.65 | Upgrade
|
| Free Cash Flow Per Share | 0.14 | -0.01 | -0.85 | -0.71 | -0.22 | Upgrade
|
| Gross Margin | 41.40% | 29.97% | 25.16% | 44.37% | 44.98% | Upgrade
|
| Operating Margin | 8.86% | -6.19% | -29.88% | -9.21% | 1.34% | Upgrade
|
| Profit Margin | -3.76% | -8.14% | -33.05% | -13.43% | -0.41% | Upgrade
|
| Free Cash Flow Margin | 4.43% | -0.41% | -37.59% | -29.72% | -8.60% | Upgrade
|
| EBITDA | 5.18 | 1.05 | -2.5 | 0.78 | 2.72 | Upgrade
|
| EBITDA Margin | 18.73% | 3.95% | -14.33% | 4.19% | 14.13% | Upgrade
|
| D&A For EBITDA | 2.73 | 2.69 | 2.72 | 2.49 | 2.46 | Upgrade
|
| EBIT | 2.45 | -1.64 | -5.22 | -1.71 | 0.26 | Upgrade
|
| EBIT Margin | 8.86% | -6.19% | -29.88% | -9.21% | 1.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.